Atorvastatin Calcium Tablet, Film Coated
Product Images NDC 72603-404

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 72603-404). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northstar Rxllc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (E84506d1 Dcd8 478c Ac0b 4328b0709494 01)

FDA Label Image

Figure1 (E84506d1 Dcd8 478c Ac0b 4328b0709494 02)

Figure1 (E84506d1 Dcd8 478c Ac0b 4328b0709494 02)
This text provides information about the cumulative incidence (%) at different time points along with hazard ratio (HR), confidence interval, and p-value for a specific event. It mentions a HR of 0.64 with a confidence interval of 0.50 to 0.83 and a p-value of 0.0005. The data seems to be related to a study or analysis conducted over a period of 3.5 years.*
FDA Label Image

Figure2 (E84506d1 Dcd8 478c Ac0b 4328b0709494 03)

Figure2 (E84506d1 Dcd8 478c Ac0b 4328b0709494 03)
This text provides information on the clinical trial results involving Atorvastatin. It includes a hazard ratio of 0.63 with a confidence interval of 0.48-0.83 and a p-value of 0.001. The data pertains to the time to the first primary endpoint over a four-year follow-up period.*
FDA Label Image

Figure3 (E84506d1 Dcd8 478c Ac0b 4328b0709494 04)

Figure3 (E84506d1 Dcd8 478c Ac0b 4328b0709494 04)
This text presents data on the subjects experiencing an event related to different doses of Atorvastatin (10mg and 80mg). The hazard ratio (HR) with confidence interval (0.69-0.89) and p-value (P=0.0002) for the Atorvastatin 80mg dose is given. The graph at the bottom displays the time to the first major cardiovascular endpoint over years.*
FDA Label Image

10mg-100's Tablets (E84506d1 Dcd8 478c Ac0b 4328b0709494 05)

10mg-100's Tablets (E84506d1 Dcd8 478c Ac0b 4328b0709494 05)
This is information about Atorvastatin Calcium Tablets, USP, with a quantity of 100 tablets per container. The manufacturer is Narkea Orara, located at Timachl Rd, in California. The tablets are a product of HDA, with the NDC code 7260340302. The tablets contain 10 mg of Atorvastatin. The storage conditions recommend room temperature.*
FDA Label Image

20 mg-100's Tablets (E84506d1 Dcd8 478c Ac0b 4328b0709494 06)

20 mg-100's Tablets (E84506d1 Dcd8 478c Ac0b 4328b0709494 06)
This text provides information about Atorvastatin Calcium Tablets. Each tablet contains 20 mg of Atorvastatin. The NDC number is 72603-404-02. It also mentions the importance of keeping the medication and all other medications out of the reach of children.*
FDA Label Image

40mg-100's Tablets (E84506d1 Dcd8 478c Ac0b 4328b0709494 07)

40mg-100's Tablets (E84506d1 Dcd8 478c Ac0b 4328b0709494 07)
This is a description for Atorvastatin Calcium Tablets, USP with a strength of 40 mg per tablet. The product is labeled with the code NOG 7260340502.*
FDA Label Image

80mg-100's Tablets (E84506d1 Dcd8 478c Ac0b 4328b0709494 08)

80mg-100's Tablets (E84506d1 Dcd8 478c Ac0b 4328b0709494 08)
This text provides information about Atorvastatin Calcium Tablets, USP, containing 80 mg per tablet. The tablets come in a packaging of 30 tablets, with a suggested usual dosage. It also includes storage instructions and prescribing information. The product is labeled with identifying numbers for NDC codes.*
FDA Label Image

10mg Blister Pack (E84506d1 Dcd8 478c Ac0b 4328b0709494 09)

FDA Label Image

20mg-blisterpack (E84506d1 Dcd8 478c Ac0b 4328b0709494 10)

FDA Label Image

40mg-blisterpack (E84506d1 Dcd8 478c Ac0b 4328b0709494 11)

FDA Label Image

80mg-blisterpack (E84506d1 Dcd8 478c Ac0b 4328b0709494 12)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.